CA1031355A - C10-c20 alkyl furoylacetic acid derivatives as hypolipidemic agents - Google Patents

C10-c20 alkyl furoylacetic acid derivatives as hypolipidemic agents

Info

Publication number
CA1031355A
CA1031355A CA194,209A CA194209A CA1031355A CA 1031355 A CA1031355 A CA 1031355A CA 194209 A CA194209 A CA 194209A CA 1031355 A CA1031355 A CA 1031355A
Authority
CA
Canada
Prior art keywords
furoylacetic
alkyl
acid derivatives
hypolipidemic agents
hypolipidemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA194,209A
Other languages
English (en)
French (fr)
Other versions
CA194209S (en
Inventor
Roger A. Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Ltd Canada
Original Assignee
Richardson Merrell Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Canada Ltd filed Critical Richardson Merrell Canada Ltd
Application granted granted Critical
Publication of CA1031355A publication Critical patent/CA1031355A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
CA194,209A 1973-04-02 1974-03-06 C10-c20 alkyl furoylacetic acid derivatives as hypolipidemic agents Expired CA1031355A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/347,232 US4000164A (en) 1973-04-02 1973-04-02 Hypolipidemic agents

Publications (1)

Publication Number Publication Date
CA1031355A true CA1031355A (en) 1978-05-16

Family

ID=23362868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA194,209A Expired CA1031355A (en) 1973-04-02 1974-03-06 C10-c20 alkyl furoylacetic acid derivatives as hypolipidemic agents

Country Status (13)

Country Link
US (1) US4000164A (xx)
JP (1) JPS5844663B2 (xx)
AU (1) AU473144B2 (xx)
BE (1) BE813041A (xx)
CA (1) CA1031355A (xx)
CH (1) CH603615A5 (xx)
DE (1) DE2414252A1 (xx)
FR (1) FR2223031B1 (xx)
GB (1) GB1417103A (xx)
NL (1) NL7404218A (xx)
PH (1) PH24978A (xx)
SE (1) SE415255B (xx)
ZA (1) ZA741421B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032647A (en) * 1975-06-16 1977-06-28 Richardson-Merrell Inc. Substituted thenoylacetic acid and esters
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB1540917A (en) * 1976-08-06 1979-02-21 Wassermann Spa A Furan derivatives for use as pharmaceutical products particularly for the treatment of rheumatic illnesses and a method for their preparation
CA1104574A (en) * 1976-12-20 1981-07-07 Roger A. Parker Antirhinovirus agents
US4169202A (en) * 1978-06-05 1979-09-25 American Home Products Corporation Process for preparing 4,5-dihydro-4-oxofuran-2-carboxylic acid derivatives
US4980371A (en) * 1988-12-21 1990-12-25 Merrell Dow Pharmaceuticals Antiretroviral furan ketones
US4977185A (en) * 1988-12-21 1990-12-11 Merrell Dow Pharmaceuticals Antiretroviral aryloxy substituted furan ketones
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834789A (en) * 1955-02-15 1958-05-13 Sadolin & Holmblad As Process of preparing lower lakyl 2, 3, 6-trihydroxybenzoate, and intermediates therefor

Also Published As

Publication number Publication date
SE415255B (sv) 1980-09-22
JPS49127964A (xx) 1974-12-07
JPS5844663B2 (ja) 1983-10-04
DE2414252C2 (xx) 1988-02-18
DE2414252A1 (de) 1974-10-17
AU6649674A (en) 1975-09-11
NL7404218A (xx) 1974-10-04
GB1417103A (en) 1975-12-10
PH24978A (en) 1990-12-26
FR2223031B1 (xx) 1977-01-21
CH603615A5 (xx) 1978-08-31
FR2223031A1 (xx) 1974-10-25
BE813041A (fr) 1974-07-15
US4000164A (en) 1976-12-28
AU473144B2 (en) 1976-06-17
ZA741421B (en) 1975-01-29

Similar Documents

Publication Publication Date Title
AU475759B2 (en) Detergent composition
CA1030420A (en) Detergent composition
CA1026639A (en) Detergent compositions
AU6640974A (en) Hypolipidemic agents
CA1034005A (en) Detergent composition
CA1031355A (en) C10-c20 alkyl furoylacetic acid derivatives as hypolipidemic agents
CA969549A (en) 2-anilino-nicotinic acid derivatives
CA1009920A (en) Detergent composition
CA1034118A (en) Oxamic acid derivatives
CA1033255A (en) Detergent compositions
CA1011213A (en) Detergent compositions
CA1029389A (en) 4-phenylbenzylidenemalonic acid derivatives as light-protective agents
CA1019759A (en) N-triiodobenzyl-carbamic acid derivatives as x-ray contrast agents
AU499409B2 (en) Cephalasporanic acid derivatives
CA1020039A (en) Liquid detergent compositions
CA1034577A (en) Thienopyridine-carboxylic acid derivatives
CA1014549A (en) Methyleneaminopenicillanic acid derivatives
CA994338A (en) Compositions containing heterocyclic bronchodilating agents
CA1013749A (en) 2-alkoxy-4-phthalimido-5-halobenzoic acid compounds
CA1029630A (en) Detergent composition
AU492953B2 (en) 4-pyridoxic acid derivatives as light-screening agents
AU493048B2 (en) Aqueous detergent composition
AU494066B2 (en) Alkyl esters
AU7983275A (en) 4-pyridoxic acid derivatives as light-screening agents
AU486111B2 (en) 4-phenyl-5-sulphamylmenzoic acid derivatives